BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Junshida (Ongericimab) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Junshida (Ongericimab)\, from ClinicalTri
 als.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07106034-1053@assetmemo.bio
DTSTAMP:20261121T004019Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Junshida (Ongericimab): Phase 2 readout est. (NCT07106034)
DESCRIPTION:Junshida (Ongericimab)\, phase 2.\nStudy: Standard Second-line 
 Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a 
 Single-arm Phase II Trial\nEstimated primary completion: 31 July 2027. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/ongericimab#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT07106034
URL:https://assetmemo.bio/drug/ongericimab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
